[1] CLÁUDIA CAMACHO J R Helena Tomás. Use of Half-Generation PAMAM Dendrimers (G0.5-G3.5) with Carboxylate End-Groups to Improve the DACHPtCl2 and 5-FU Efficacy as Anticancer Drugs.[J]. Molecules, 2021, 26 10. DOI:
10.3390/molecules26102924[2] S. SADEKAR . Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin[J]. International Journal of Pharmaceutics, 2013, 456 1: Pages 175-185. DOI:
10.1016/j.ijpharm.2013.07.071[3] GABRIELLA CAMINATI Donald A T Nicholas J Turro. Photophysical investigation of starburst dendrimers and their interactions with anionic and cationic surfactants[J]. Journal of the American Chemical Society, 1990, 112 23: 8515-8522. DOI:
10.1021/ja00179a041[4] BING WANG . Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers[J]. International Journal of Pharmaceutics, 2010, 395 1: Pages 298-308. DOI:
10.1016/j.ijpharm.2010.05.030[5] MAGDALENA LABIENIEC Teresa G. Preliminary biological evaluation of poli(amidoamine) (PAMAM) dendrimer G3.5 on selected parameters of rat liver mitochondria[J]. Mitochondrion, 2008, 8 4: Pages 305-312. DOI:
10.1016/j.mito.2008.07.001[6] TISHA C. KING HEIDEN . Developmental toxicity of low generation PAMAM dendrimers in zebrafish[J]. Toxicology and applied pharmacology, 2007, 225 1: Pages 70-79. DOI:
10.1016/j.taap.2007.07.009[7] DEBORAH S GOLDBERG P W S Hamidreza Ghandehari. Cellular entry of G3.5 poly (amido amine) dendrimers by clathrin- and dynamin-dependent endocytosis promotes tight junctional opening in intestinal epithelia.[J]. Pharmaceutical Research, 2010, 27 8: 1547-1557. DOI:
10.1007/s11095-010-0153-3